Cargando…
Topiramate-induced hyperammonemic encephalopathy in a patient with mental retardation: A case report and review of the literature
Hyperammonemia is an uncommon side effect of topiramate (TPM) that has only been reported when it is used as an adjunct to valproate. We report a patient with mental retardation who developed reversible encephalopathy from TPM. Ammonia level was monitored during the course of TPM treatment. This pat...
Autores principales: | Tantikittichaikul, Sahawat, Johnson, Justine, Laengvejkal, Pavis, DeToledo, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576360/ https://www.ncbi.nlm.nih.gov/pubmed/26543812 http://dx.doi.org/10.1016/j.ebcr.2014.09.001 |
Ejemplares similares
-
Hyperammonemic Encephalopathy due to Valproic Acid and Topiramate Interaction
por: Twilla, Jennifer D., et al.
Publicado: (2014) -
Valproate-induced hyperammonemic encephalopathy enhanced by topiramate and phenobarbitone: A case report and an update
por: Vivekanandan, S., et al.
Publicado: (2010) -
Hypoxic respiratory failure due to hyperammonemic encephalopathy induced by concurrent use of valproic acid and topiramate, a case report and review of the literature
por: Raru, Yonas, et al.
Publicado: (2018) -
Valproate-Induced Hyperammonemic Encephalopathy
por: Farooq, Faiza, et al.
Publicado: (2017) -
Pronounced reversible hyperammonemic encephalopathy associated with combined valproate–topiramate therapy in a 7-year-old girl
por: Weise, Sebastian, et al.
Publicado: (2015)